CGON vs SNY
CG Oncology, Inc. Common stock (CGON) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
SNY (SNY) common stock.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
SNY does not have a complete income-statement cache yet.
CGON currently screens at market cap $4.74B. SNY currently screens at market cap $0.
Not investment advice. Open the CGON and SNY stock pages for the full models.
Not investment advice.